MiNK Therapeutics, Inc.INKTNASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank100
5Y CAGR+18.7%
Studio
Year-over-Year Change

Return on invested capital

5Y CAGR
+18.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2.4x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024859.68%+156.9%
2023334.60%+195.0%
2022-352.16%-350.0%
2021-78.26%-170.1%
2020111.68%-69.4%
2019364.72%-